Teva
Flagged · AvoidThe world's largest generic drug maker, which agreed to a $6.6B opioid settlement for illegally marketing addictive painkillers that devastated communities across the U.S.
Last updated June 10, 2026
↓ Skip to 4 ethical alternativesReasons to avoid
Issues span:ConsumerEnvironmentLaborAntitrust
- Teva agreed to pay $4.25 billion to settle opioid crisis lawsuits with all 50 U.S. states, one of the largest pharmaceutical opioid settlements in history. The Nevada settlement in June 2023 was the final state agreement, completing a nationwide deal that found Teva had aggressively marketed addictive painkillers while downplaying addiction risks.
- The U.S. Department of Justice charged Teva with conspiring to fix prices, rig bids, and allocate customers for generic drugs including a common cholesterol medication and two infection treatments, overcharging consumers by more than $350 million. Teva paid a $225 million criminal fine in August 2023 under a deferred prosecution agreement.
- A Teva pharmaceutical manufacturing subsidiary in Guayama, Puerto Rico agreed in April 2020 to pay $539,784 in penalties after the EPA and DOJ found it had violated the Clean Air Act, Clean Water Act, Resource Conservation and Recovery Act, and Emergency Planning and Community Right-to-Know Act at its facility.
- The SEC and DOJ announced a $519 million settlement with Teva in December 2016 — the largest FCPA fine ever imposed on a pharmaceutical company — after finding the company had bribed government officials in Russia, Ukraine, and Mexico to increase sales of its multiple sclerosis drug. Teva made more than $214 million in illicit profits through the bribery scheme.
- The Federal Trade Commission reached a global settlement with Teva in February 2019 banning it from entering into reverse-payment agreements that pay generic competitors to delay entering the market with lower-cost alternatives. The settlement resolved three separate federal antitrust lawsuits and permanently prohibited the world's largest generic drugmaker from blocking price competition.
- Teva recalled over 580,000 bottles of the blood pressure medication prazosin in 2025 after testing found contamination with N-nitroso Prazosin, a potential carcinogen, at levels above FDA acceptable limits. It was the latest in a pattern of quality control failures that have led to multiple Teva drug recalls in recent years.
Ethical alternatives
Pharmacy
Ask for Different Generics
Request generic medications from other manufacturers. Use GoodRx to compare prices.
Visit →
Mark Cuban Cost Plus Drugs
Transparent pricing on generic medications at near-cost prices.
🤝 Fair Trade
Visit →Patient Assistance Programs
Find programs that provide free or low-cost medications.
📚 Free Resource👥 Community Driven
Visit →Common Questions
- Should I avoid Teva?
- Teva agreed to pay $4.25 billion to settle opioid crisis lawsuits with all 50 U.S. states after aggressively marketing addictive painkillers while downplaying addiction risks. The DOJ also charged the company with price-fixing generic drugs, overcharging consumers by more than $350 million, resulting in a $225 million criminal fine in 2023. The company also paid $519 million in 2016 for bribing government officials in Russia, Ukraine, and Mexico.
- Why should I avoid Teva?
- Teva is at the center of three major enforcement actions: opioid settlement, criminal price-fixing, and foreign bribery. It has also recalled over 580,000 bottles of blood pressure medication contaminated with a potential carcinogen, the latest in a pattern of quality control failures. The FTC banned the company from paying generic competitors to delay cheaper alternatives from reaching market.
- What are the best ethical alternatives to Teva?
- Mark Cuban Cost Plus Drugs offers generic medications at transparent near-cost pricing with no hidden markups. You can also ask your pharmacist to dispense the same generic from a different manufacturer. GoodRx helps compare prices across pharmacies to find the lowest available cost for your prescriptions.